Keyphrases
Glucose-6-phosphate Dehydrogenase (G6PD)
100%
Acute Myeloid Leukemia
100%
FMS-like Tyrosine Kinase 3 (FLT3)
100%
Ataxia Telangiectasia mutated
100%
Inhibitor Resistance
100%
Redox Metabolism
100%
Acute Myeloid Leukemia Cells
30%
Mitochondrial Oxidative Stress
20%
Cell Growth
10%
Apoptosis
10%
Cell Survival
10%
Glutathione
10%
Therapeutic Strategies
10%
Induced Apoptosis
10%
RNA Interference
10%
Monotherapy
10%
Downstream Effectors
10%
Metabolomics
10%
Activating mutation
10%
Central Carbon Metabolism
10%
Synthetic Lethal
10%
Leukemic Cells
10%
Long-term Remission
10%
Genetic Targets
10%
Inhibitor Therapy
10%
Antioxidant Factors
10%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Glucose 6 Phosphate Dehydrogenase
100%
Redox Metabolism
100%
Ataxia Telangiectasia
100%
FMS-Like Tyrosine Kinase 3
100%
Leukemia Cell
30%
Programmed Cell Death
20%
Oxidative Stress
20%
Antioxidant
10%
In Vitro
10%
Cell Survival
10%
Cell Growth
10%
Monotherapy
10%
Glutathione
10%
Metabolome
10%
Carbon Metabolism
10%
RNAI
10%
Biochemistry, Genetics and Molecular Biology
Glucose-6-Phosphate Dehydrogenase
100%
Myeloid
100%
Ataxia Telangiectasia Mutated
100%
FMS-Like Tyrosine Kinase 3
100%
Redox Metabolism
100%
Oxidative Stress
20%
Cell Survival
10%
Cell Growth
10%
Genetics
10%
Metabolome
10%
Carbon Metabolism
10%
Glutathione
10%
RNAI
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Glucose 6 Phosphate Dehydrogenase
100%
Ataxia Telangiectasia
100%
Protein Kinase Fer
100%
Antioxidant
10%
Glutathione
10%
Monotherapy
10%
Elimination
10%
Remission
10%